Tafamidis meglumine 20mg capsules

previously Tafamidis 20mg capsules

SNOMED code
22155011000001108
Named
Active compound
Tafamidis
Preferred name basis
rINN - Recommended International Non-proprietary
previously
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
1 capsule, capsule
Ingredients
Tafamidis meglumine — 20 mg based on ingredient substance
Form & Route
capsule.oral
Oral capsule, Oral
Controlled drug
No Controlled Drug Status

Products

Vyndaqel 20mg capsules (Pfizer Ltd)

Vyndaqel 20mg capsules

SNOMED code
22112211000001104
Supplier
Pfizer Ltd
Licensed as
Medicines - MHRA/EMA
EMA (European Medicines Agency) Monitoring
▼ Yes, black triangle marked
Availability restrictions
None
Licensed route
Oral
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules
22112311000001107   ref. pack		💯 Available

Legal category: POM		5013457015027

End: 5415062348178
NHS Indicative Price
£10,685		• Hospital
  • • Prescription Charges
  • • Dispensing Fees
  • • Broken Bulk
 —

Reference packs

Tafamidis meglumine 20mg capsules 30 capsule
SNOMED code
22112111000001105
Quantity and unit
30 capsule
Packs